Experienced in Cholangiocarcinoma (Bile Duct Cancer)

Shengping L. Li

State Key Laboratory Of Oncology In South China, 
Guangzhou, CN 
Experienced in Cholangiocarcinoma (Bile Duct Cancer)
State Key Laboratory Of Oncology In South China, 
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Shengping Li practices in Guangzhou, China. Li is rated as an Experienced expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Their top areas of expertise are Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Liver Cancer, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Their clinical research consists of co-authoring 121 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 9 articles in the study of Cholangiocarcinoma (Bile Duct Cancer).

Locations

State Key Laboratory Of Oncology In South China, Guangzhou, China
Other Locations
Chongqing Key Laboratory Of Child Nutrition And Health, Chongqing, China
MOE Key Laboratory Of Intelligent Manufacturing, Shantou, 515063, China
Zhuhai, 519000, China
Chinese Academy Of Medical Sciences And Peking Union Medical College, Shenzhen, 518116, China
National Key Laboratory Of Science And Technology On Helicopter Transmission, Nanjing, 210016, China
State Key Laboratory Of Heavy Oil Processing, Beijing, P.R. China, Changping, 102249, China
510060, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

121 Total Publications

Development of a nomogram integrating immune checkpoints, fibrosis indicators, and clinicopathological characteristics to predict overall survival in pancreatic cancer: a retrospective analysis.
Development of a nomogram integrating immune checkpoints, fibrosis indicators, and clinicopathological characteristics to predict overall survival in pancreatic cancer: a retrospective analysis.
Journal: Frontiers in immunology
Published: August 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Li's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile